The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
about
Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1CPresage of oncolytic virotherapy for oral cancer with herpes simplex virus.XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.Dermal fibroblasts tumor suppression of ras-transformed keratinocytes is associated with induction of squamous cell differentiationModulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrateImproved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.Relationship between the induction of leukemia cell differentiation and the enhancement of reporter gene expression in 3T3 Swiss cellsInhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1.Activity of differentiation-inducing agents and conventional drugs in head and neck cancer xenografts.Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.The importance of the induction of gene expression and differentiation by cytotoxic chemotherapy.The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells.GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamineInduction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate.Induction of heat labile alkaline phosphatase by butyrate in differentiating endometrial cells.Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment.Epidermal growth factor induces terminal differentiation in human epidermoid carcinoma cells.Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsClinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells.JNK/SAPK mediates doxorubicin-induced differentiation and apoptosis in MCF-7 breast cancer cells.Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell.
P2860
Q28572821-71532CC2-ED74-475C-8A1C-C2C8C7EA5E3CQ33603748-1FA9C473-0C67-43AF-AC9B-55CE3C456259Q34100957-17F50266-6CF7-446B-BE9C-A221FFE9C494Q34683871-586EE88A-6A17-4237-891B-7B4DFCE9193AQ35032944-72D651D1-C163-46F8-95EB-171063826E4FQ35833873-B47B8744-3660-4FD1-8237-E00624D4DA54Q36389588-EDFB0C3E-7CFD-43B8-8F04-BC170CE085F7Q36642487-42566B13-772C-4F5D-8433-86CEFB245CB5Q37423583-AB81BC92-7DEF-45A2-B991-FDA5BD3F052DQ37428066-F8B5EDED-F02C-455F-8F0A-23415ED1A386Q39102651-15B042F4-B7C9-4196-A846-9FAD81907C59Q39102897-CC261D2C-5538-4194-88D1-7013894B7BA6Q39522308-6B623E52-E380-4256-B4B4-6F7F8BB181AEQ39573244-D52D79FD-8490-4BBC-9F49-31955B580468Q40437082-B7A6AA5F-7C95-4A2B-ABC7-FB4BD98F875BQ40968416-D225FA00-47AF-409F-8C55-000EB5342088Q41160198-E1133985-8D86-4CA6-B79F-B04640936246Q41286653-8051CB1C-82C4-4D89-9BCE-0473C7A9FDD5Q41320266-24637FE3-DA7D-474E-8F3C-EBFC06D113FCQ41389626-B91FA7D8-0489-45A3-93CF-AC495832C639Q41531974-347F7F05-9B68-422D-8D16-1766E81E3584Q41850853-04B46FAC-7A66-44A4-8706-8BFF2542182FQ41930899-777CC643-3F58-4846-96EC-62D422972367Q47259985-1A2A95AD-7709-4313-9CC8-37764F953D6FQ53523919-28560342-4AA3-46B5-B28D-96CA915745E2Q53744555-A7C42601-CCB6-46B5-8FCE-71FB2C499344Q54254464-7C27E661-8C9F-4CC8-BBBE-FDCFC5EFB729
P2860
The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@ast
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@en
type
label
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@ast
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@en
prefLabel
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@ast
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@en
P2860
P356
P1476
The 1985 Walter Hubert lecture ...... otential therapeutic approach.
@en
P2093
A C Sartorelli
P2860
P2888
P304
P356
10.1038/BJC.1985.193
P407
P577
1985-09-01T00:00:00Z